NEW YORK, Sept. 17, 2019 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Karyopharm Therapeutics Inc. (“Karyopharm” or the “Company”) (NASDAQ: KPTI) and certain of its officers. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. Karyopharm also claimed that selinexor …